These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 15028477

  • 21. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
    Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML.
    Clin Cancer Res; 1999 Dec; 5(12):4105-10. PubMed ID: 10632347
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer.
    Valdman A, Fang X, Pang ST, Ekman P, Egevad L.
    Prostate; 2004 Sep 01; 60(4):367-71. PubMed ID: 15264249
    [Abstract] [Full Text] [Related]

  • 25. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Garcia FU, Haber MM, Chen X.
    Prostate; 2007 Nov 01; 67(15):1686-92. PubMed ID: 17879949
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F, Epstein JI.
    Am J Surg Pathol; 2008 Jul 01; 32(7):1060-7. PubMed ID: 18496142
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
    Wang W, Bergh A, Damber JE.
    Prostate; 2009 Sep 15; 69(13):1378-86. PubMed ID: 19507201
    [Abstract] [Full Text] [Related]

  • 33. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Clin Cancer Res; 2004 Dec 15; 10(24):8472-8. PubMed ID: 15623627
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
    Alcaraz A, Barranco MA, Corral JM, Ribal MJ, Carrió A, Mallofré C, Llopis J, Cetina A, Alvarez-Vijande R.
    Prostate; 2001 Apr 15; 47(1):29-35. PubMed ID: 11304727
    [Abstract] [Full Text] [Related]

  • 36. Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer.
    Carvalho JR, Filipe L, Costa VL, Ribeiro FR, Martins AT, Teixeira MR, Jerónimo C, Henrique R.
    Apoptosis; 2010 Aug 15; 15(8):956-65. PubMed ID: 20464497
    [Abstract] [Full Text] [Related]

  • 37. Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer. Further evidence for field effect in prostatic carcinogenesis.
    Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R.
    Hum Pathol; 2011 Dec 15; 42(12):1931-6. PubMed ID: 21676431
    [Abstract] [Full Text] [Related]

  • 38. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
    Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP.
    Cancer Res; 2005 Feb 15; 65(4):1164-73. PubMed ID: 15734999
    [Abstract] [Full Text] [Related]

  • 39. Distinct patterns of endothelin axis expression in primary prostate cancer.
    Godara G, Pecher S, Jukic DM, D'Antonio JM, Akhavan A, Nelson JB, Pflug BR.
    Urology; 2007 Jul 15; 70(1):209-15. PubMed ID: 17656249
    [Abstract] [Full Text] [Related]

  • 40. Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.
    Rasiah KK, Kench JG, Gardiner-Garden M, Biankin AV, Golovsky D, Brenner PC, Kooner R, O'neill GF, Turner JJ, Delprado W, Lee CS, Brown DA, Breit SN, Grygiel JJ, Horvath LG, Stricker PD, Sutherland RL, Henshall SM.
    Cancer Epidemiol Biomarkers Prev; 2006 Apr 15; 15(4):711-6. PubMed ID: 16614113
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.